Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bemiparin sodium for diabetic foot ulcers
2006-005201-60Phase 3Completed
- Sponsor
- Laboratorios Farmacéuticos ROVI
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bemiparin in diabetic foot ulcer (DFU) (2 arms), sponsored by Laboratorios Farmacéuticos ROVI. Primary endpoint: Complete healing or significant improvement of the ulcer. Started Mar 2010; status: completed.
02
Drugs
bemiparin
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on 2006-005201-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005201-60.